Michele D. Stanchina, DO, MS¹, Russ Kuker, MD^2*, Sunwoo Han, PhD^3*, Fei Yang, PhD^2*, Mark K Polar, MD^2*, Jillian Lorayne Lykon, PharmD^4*, Tracy Crane, PhD, RDN^5*, Melissa Lopez-Pentecost, PhD, RDN^5*, Craig H. Moskowitz, MD¹ and Juan Pablo Alderuccio, MD¹

¹Sylvester Comprehensive Cancer Center, Division of Hematology, University of Miami, Miller School of Medicine, Miami, FL
²Department of Radiology, Division of Nuclear Medicine, University of Miami, Miller School of Medicine, Miami, FL
³Biostatistics and Bioinformatics Shared Resource, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
⁴Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
⁵Sylvester Comprehensive Cancer Center, Medical Oncology and Public Health, University of Miami, Miami, FL

Amira Marouf, MD, PhD¹, Cedric Rossi, MD, PhD^2,3, Tesla Murairi^4*, Fanny Cherblanc, PhD^5*, Loic Chartier^6*, Hervé Ghesquieres, MD, PhD^7* and Bénédicte Deau Fischer, MD^8,9*

¹INSERM U1163 Laboratory of cellular and molecular mechanisms of hematological disorders and therapeutic implications, Institut IMAGINE, Université Paris Cité, PARIS, France
²CHU Dijon, DIJON, France
³INSERM 1231, Dijon, France
⁴Department of Biostatistics, Lymphoma Academic Research Organisation (LYSARC), Lyon, France
⁵Lymphoma Academic Research Organisation, Lyon, France
⁶Department of Biostatistics, Lymphoma Academic Research Organization (LYSARC), Lyon, France
⁷Department of Hematology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France
⁸Department of Hematology, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France
⁹Groupe Hospitalier privé Ambroise Paré-Hartmann, Département Recherche Innovation, Neuilly Sur Seine, France

Gaurav Varma, MD, MSPH^1,2, Maya C. Rosenberg, MD^2*, Erica C. Agbadiba, BS^3*, Austin H. Yeung, BS^4*, Ayo S. Falade, MD, MBA^5,6*, Marcus P. Watkins, PhD^7*, Grace T. Baek^8*, Herman van Besien, MD^1*, Kelsey Baron, MD⁹, Meghana K. Subramanian, MD^10*, Sara Prischak, BS^11*, Joe D. Lukowski, MPH^12*, Christopher D’Angelo, MD^12*, Jakub Svoboda, MD¹¹, Joanna M. Rhodes, MD¹⁰, Harsh R. Shah, DO⁹, Samuel Yamshon, MD^1*, Ajay K. Gopal, MD¹³, Nancy L. Bartlett, MD¹⁴, Reid W. Merryman, MD⁵, Ranjana H. Advani, MD⁴, Sairah Ahmed, MD³ and Catherine S. Diefenbach, MD²

¹Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine/NewYork-Presbyterian, New York, NY
²Perlmutter Cancer Center, NYU Langone Health, New York, NY
³Department of Lymphoma/Myeloma and Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Stanford Cancer Institute, Stanford University, Stanford, CA
⁵Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁶Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN
⁷Division of Oncology, Washington University School of Medicine, St. Louis, MO
⁸Fred Hutchinson Cancer Center, University of Washington, Seattle, WA
⁹Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
¹⁰Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
¹¹Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
¹²Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE
¹³University of Washington, Seattle, WA
¹⁴Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO

Fjoralba Kristo^1*, Flora Mazerolle^2*, Thibaud Alin^2*, Antoine Regnault^2*, Justin Ferdinandus, MD^3*, Karolin Behringer^3*, Janina Jablonski^3*, Peter Borchmann, MD³ and Ajibade Ashaye, MD, MS, MBA, MPH¹

¹Takeda Development Center Americas, Inc., Cambridge, MA
²Modus Outcomes, a THREAD company, Lyon, France
³German Hodgkin Study Group and Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University of Cologne, Cologne, Germany

Christopher J. Forlenza, MD¹, Opeyemi Jegede^2*, Stephen M. Ansell, MD, PhD³, Christian Steidl, MD, PhD⁴, Yasodha Natkunam, MD, PhD⁵, David W. Scott, MBChB, PhD⁶, Neha Mehta-Shah, MD⁷, Jennifer E. Amengual, MD⁸, Peter D. Cole, MD⁹, Brad S. Kahl, MD¹⁰ and Catherine S. Diefenbach, MD¹¹

¹Memorial Sloan Kettering Cancer Center, New York, NY
²CIMAC-CIDC Network, Department of Data Science, Boston, MA
³Division of Hematology, Mayo Clinic, Rochester, MN
⁴Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
⁵Department of Pathology, Stanford University School of Medicine, Stanford, CA
⁶Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada
⁷Siteman Cancer Center, Washington University School of Medicine, Olivette, MO
⁸Division of Hematology & Oncology, Columbia University Irving Medical Center, New York
⁹Division of Pediatric Hematology/Oncology, Rutgers Cancer Institute, New Brunswick, NJ
¹⁰Department of Medicine, Washington University School of Medicine, St. Louis, MO
¹¹Perlmutter Cancer Center at NYU Langone Health, New York, NY

Paul J. Bröckelmann, MD^1*, Ina Bühnen, MSc^1*, Josée M Zijlstra, MD, PhD², Stephan Mathas, MD^3*, Katrin S Roth, MD^4*, Maria Garcia-Marquez, PhD^5*, Christian Sillaber, MD^6*, Julia Meissner, MD^7*, Alexander Fossa, MD^8*, Richard Greil, MD⁹, Karolin Trautmann-Grill^10*, Johannes Rosenbrock, MD^11*, Wouter Plattel, MD, PhD^12*, Hans A Schlösser, MD^13*, Carsten Kobe, MD^4*, Michael Fuchs, MD^14*, Peter Borchmann, MD¹ and Christian Baues, MD^15*

¹University of Cologne, Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, and Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), and German Hodgkin Study Group (GHSG), Cologne, Germany
²Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
³Charité Berlin, Berlin, DEU
⁴Department of Nuclear Medicine, University Hospital of Cologne, Cologne, Germany
⁵Department of General, Visceral, Cancer and Transplantation Surgery, University of Cologne, Cologne, Germany
⁶Medical University Vienna, Vienna, AUT
⁷Medicine V, University Hospital of Heidelberg, Heidelberg, Germany
⁸Department of Oncology, Oslo University Hospital, Oslo, Norway
⁹3rd Medical Dept. with Haematology, Medical Oncology, Haemostaseology, Rheumatology and Infectiology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria
¹⁰University Hospital Carl Gustav Carus, Dresden, Germany
¹¹Department of Radiation Oncology and Cyberknife Center, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
¹²Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
¹³Center for Molecular Medicine Cologne and Department of General, Visceral, Cancer and Transplantation Surgery, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany
¹⁴Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany
¹⁵Department of Radiation Oncology, University Hospital of Ruhr-Universität Bochum, Marien Hospital Herne, Herne, Germany

Alayna M. Santarosa, MPH^1,2*, Nivetha Ganesan, MPH^1*, Tiffany Chang, MS^1*, Kelly Hannigan^3*, Ellie Casper, MS, DPT^2*, Gunjan L. Shah, MD^4,5, Alexander P. Boardman, MD^2*, Philip Caron, MD², Kevin A. David, MD^2*, Ahmet Dogan, MD, PhD¹, Zachary D. Epstein-Peterson, MD², Lorenzo Falchi, MD², Paola Ghione, MD², Paul A. Hamlin, MD², Steven Horwitz, MD², Andrew M. Intlekofer, MD, PhD², William T. Johnson, DO⁶, Ariel Krivisky, RN^7*, Anita Kumar, MD⁸, Jennifer Kimberly Lue, MD², Efrat Luttwak, MD², Ariela Noy, MD², Colette Owens, MD², Maria Lia Palomba, MD², Gilles Salles, MD, PhD⁹, Heiko Schoder, MD^1*, Raphael E. Steiner, MD², Robert Stuver, MD², Pallawi Torka, MD², Santosha A. Vardhana, MD, PhD², Joachim Yahalom, MD¹⁰, Andrew D. Zelenetz, MD, PhD², Craig H. Moskowitz, MD¹¹ and Alison Moskowitz, MD²

¹Memorial Sloan Kettering Cancer Center, New York, NY
²Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
³Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NY
⁴Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York
⁶Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Lymphoma Department, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁸Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Short Hills, NJ
⁹Lymphoma Service Chief, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁰Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
¹¹Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL

Tine Kopp^1*, Jonas Banefelt^2*, Mathias Lilja^2*, Susan Hall^3*, Laura Hendrix^3*, Sigrid DaVeiga^3* and John Diaz-Decaro, PhD, MS^4*

¹Quantify Research, Copenhagen, Denmark
²Quantify Research, Stockholm, Sweden
³Moderna Therapeutics, Inc, Cambridge
⁴Moderna Therapeutics, Inc, Potomac, MD

Grace T. Baek^1,2*, Gaurav Varma, MD, MSPH^3,4, Samuel Yamshon, MD^4*, Herman van Besien, MD^4*, Nancy L. Bartlett, MD⁵, Marcus P. Watkins, PhD^6*, Harsh R. Shah, DO⁷, Kelsey Baron, MD⁷, Reid W. Merryman, MD⁸, Ayo S Falade, MD, MBA^9,10, Jakub Svoboda, MD¹¹, Sara Prischak, BS^11*, Christopher R D'Angelo, MD¹², Joe D. Lukowski, MPH^13*, Ranjana H. Advani, MD¹⁴, Austin H. Yeung, BS^15*, Maya C. Rosenberg, MD^3*, Jenna M. Voutsinas, MPH^16*, Mengyang Di, MD, PhD^17,18, Ryan C Lynch, MD^17,18, Christina Poh, MD^17,18, Vikram Raghunathan, MD^17,18*, Mazyar Shadman, MD, MPH^17,18, Stephen D. Smith, MD^17,18, Brian G. Till, MD^1,18, Chaitra S. Ujjani, MD^17,18, Catherine S. Diefenbach, MD³ and Ajay K. Gopal, MD^17,18

¹Fred Hutchinson Cancer Center, University of Washington, Seattle, WA
²Fred Hutchinson/University of Washington Cancer Consortium, Seattle, WA
³Perlmutter Cancer Center, NYU Langone Health, New York, NY
⁴Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine/NewYork-Presbyterian, New York, NY
⁵Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
⁶Division of Oncology, Washington University School of Medicine, St. Louis, MO
⁷Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
⁸Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁹Division of Hematology, Mayo Clinic Comprehensive Cancer Center, Rochester, MN
¹⁰Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA
¹¹Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
¹²Division of Hematology & Oncology, Department of Internal Medicine, University of Nebraska Medical Center- Fred and Pamela Buffett Cancer Center, Omaha, NE
¹³Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE
¹⁴Department of Medicine, Division of Oncology and Hematology, Stanford University, Stanford, CA
¹⁵Stanford Cancer Institute, Stanford University, Stanford, CA
¹⁶Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
¹⁷Fred Hutchinson Cancer Center, Seattle, WA
¹⁸Division of Hematology and Oncology, University of Washington, Seattle, WA

Karla Machlab, MD¹, Vivian Aghanya^2*, Lee Mozessohn, MD³, Michael Crump, MD^4*, Danielle Rodin, MD, MPH^5*, Ning Liu, PhD^6* and Anca Prica, MD⁷

¹University of Toronto, Toronto, ON, Canada
²Institute for Clinical Evaluative Sciences, Toronto, Canada
³Sunnybrook Health Sciences Centre, Toronto, ON, Canada
⁴Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
⁵Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁶ICES, Toronto, ON, Canada
⁷Divison of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada

Tatyana Feldman, MD¹, Enrica Marchi, MD, PhD², Stephen D. Smith, MD³, Adam J. Olszewski, MD⁴, Auris O Huen, MD, PharmD^5*, Zachary D. Epstein-Peterson, MD⁶, Don A. Stevens, MD⁷, Alexander N. Starodub, MD^8*, Eric J. Feldman, MD^9*, Cristina P Rodriguez, MD^10*, John C. Reneau, MD, PhD¹¹, Jonathan E. Brammer¹¹, Ahmad H. Mattour, MD¹², Lauren C. Pinter-Brown, MD, FACP^13*, Rachelle Perea^14*, Patrick Henrick, BS^15*, Joyoti Dey, PhD, MPH^15*, Alyssa Fasciano, PhD^15*, Rahul Karnik, PhD^15*, Sagar Agarwal, PhD^15*, Ashwin Gollerkeri, MD^15*, Jared Gollob, MD^15*, Aditi Shastri, MD¹⁶ and Stefan K. Barta, MD¹⁷

¹John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
²Division of Hematology and Oncology, Department of Medicine, University of Virginia Health System, Charlottesville, VA
³Clinical Research Division, Fred Hutch Cancer Center; and Division of Oncology, University of Washington, Seattle, WA
⁴Brown University, Providence, RI
⁵Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Norton Cancer Institute, Louisville, KY
⁸The Christ Hospital Cancer Center, Cincinnati, OH
⁹Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
¹⁰University of Washington, Division of Medical Oncology, Seattle, WA
¹¹The James Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH
¹²Hematology and Oncology; Henry Ford Cancer Institute, Henry Ford Health, Detroit, MI
¹³University of California Irvine, Irvine, CA
¹⁴Kymera Therapeutics, Boston, MA
¹⁵Kymera Therapeutics, Watertown, MA
¹⁶Montefiore Medical Center, Bronx, NY
¹⁷Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA

Alexandra Dreyfuss, MD, MSTR^1*, Nivetha Ganesan, MPH^2*, Alvaro J Alencar, MD³, Alexander P. Boardman, MD^4*, Philip Caron, MD⁴, Tiffany Chang, MS^2*, Theresa Davey, MMSc, PA-C^2*, Kevin A. David, MD^4*, Ahmet Dogan, MD, PhD², Zachary D. Epstein-Peterson, MD⁴, Lorenzo Falchi, MD², Beatrice Fregonese, MPH^1*, Paola Ghione, MD, MSEpi², Paul A. Hamlin, MD⁴, Steven Horwitz, MD⁴, Brandon S. Imber, MD, MA¹, Andrew M. Intlekofer, MD, PhD⁴, Derek Isrow, MD, PhD^5*, Erel Joffe, MD^2*, William T. Johnson, DO⁶, Anita Kumar, MD⁷, Michael Lariviere, MD^8*, Jennifer Kimberly Lue, MD⁴, Efrat Luttwak, MD⁴, Michael McNicholas^8*, Zachary Moore, MD, PhD^1*, Brittney Munayirji^2*, Ariela Noy, MD⁹, Colette Owens, MD⁴, Maria Lia Palomba, MD⁴, Jaldhi Patel^8*, John P Plastaras, MD, PhD^8*, Alayna M. Santarosa, MPH^2*, Heiko Schoder, MD^2*, Gunjan L. Shah, MD¹⁰, Raphael E. Steiner, MD², Robert Stuver, MD⁴, Jakub Svoboda, MD⁸, Pallawi Torka, MD², Santosha A. Vardhana, MD, PhD⁴, Andrew D. Zelenetz, MD, PhD⁴, Gilles Salles, MD, PhD¹¹, Joachim Yahalom, MD¹, Craig H. Moskowitz, MD¹² and Alison Moskowitz, MD⁴

¹Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
²Memorial Sloan Kettering Cancer Center, New York, NY
³Sylvester Comprehensive Cancer Center, Division of Hematology, University of Miami, Miller School of Medicine, Miami Beach, FL
⁴Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Sylvester Comprehensive Cancer Center, Department of Radiation Oncology, University of Miami, Miller School of Medicine, Miami
⁶Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Short Hills, NJ
⁸School of Medicine, Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA
⁹Memorial Sloan-Kettering Cancer Ctr., New York, NY
¹⁰Transplant and Cellular Therapy Services, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹¹Lymphoma Service Chief, Memorial Sloan Kettering Cancer Center, New York, NY
¹²Sylvester Comprehensive Cancer Center, Division of Hematology, University of Miami, Miller School of Medicine, Miami, FL